ENTA Trading Below Director's Recent Buy Price
August 21, 2014 at 11:51 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 14, Enanta Pharmaceuticals, Inc.'s Director, Stephen Buckley Jr., invested $38,950.00 into 1,000 shares of ENTA, for a cost per share of $38.95..
